BioXcel Therapeutics, Inc. Class of Warrant or Right, Outstanding
BioXcel Therapeutics, Inc. (BTAI) had Class of Warrant or Right, Outstanding of 7.86 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-13
- 2026-06-30: Class of Warrant or Right, Outstanding 7.86M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 7.86M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 3.18M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 3.18M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 7.86M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 7.86M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 3.18M shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 3.18M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 5.48M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 5.79M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 1.79M shares 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |